Dimitrios Th Kremastinos
Overview
Explore the profile of Dimitrios Th Kremastinos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
2062
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Efentakis P, Andreadou I, Bibli S, Vasileiou S, Dagres N, Zoga A, et al.
Eur J Pharmacol
. 2016 Aug;
789:431-438.
PMID: 27492365
We tested the hypothesis that ranolazine (Ran) is cardioprotective in a model of ischemia /reperfusion and we elucidated the intracellular mechanism. Anesthetized rabbits were subjected to is chemia and reperfusion...
2.
Bibli S, Andreadou I, Chatzianastasiou A, Tzimas C, Sanoudou D, Kranias E, et al.
Cardiovasc Res
. 2015 Apr;
106(3):432-42.
PMID: 25870184
Aims: H2S is known to confer cardioprotection; however, the pathways mediating its effects in vivo remain incompletely understood. The purpose of the present study is to evaluate the contribution of...
3.
Andreadou I, Bibli S, Mastromanolis E, Zoga A, Efentakis P, Papaioannou N, et al.
Int J Cardiol
. 2015 Feb;
184:140-151.
PMID: 25703422
Background: We investigated the effectiveness of perconditioning (Perc) applied at different time points along with the role of RISK, SAFE, STAT5 and eNOS pathways. Methods And Results: Anesthetized rabbits were...
4.
Iliodromitis E, Cohen M, Dagres N, Andreadou I, Kremastinos D, Downey J
J Cardiovasc Pharmacol Ther
. 2015 Jan;
20(4):357-69.
PMID: 25627214
Early recanalization of the occluded culprit coronary artery clearly reduces infarct size in both animal models and patients and improves clinical outcomes. Unfortunately, reperfusion can seldom be accomplished before some...
5.
Bibli S, Iliodromitis E, Lambertucci C, Zoga A, Lougiakis N, Dagres N, et al.
J Pharm Pharmacol
. 2014 Apr;
66(8):1140-9.
PMID: 24766266
Objectives: We investigated the effects of novel selective and non-selective adenosine receptor agonists (ARs) on cardioprotection. Methods: Male rabbits divided into six groups were subjected to 30-min heart ischaemia and...
6.
Andreadou I, Mikros E, Ioannidis K, Sigala F, Naka K, Kostidis S, et al.
J Mol Cell Cardiol
. 2014 Feb;
69:4-16.
PMID: 24486195
Oleuropein, a natural phenolic compound, prevents acute doxorubicin (DXR)-induced cardiotoxicity but there is no evidence regarding its role in chronic DXR-induced cardiomyopathy (DXR-CM). In the present study, we investigated the...
7.
A case-control validation of Type D personality in Greek patients with stable coronary heart disease
Christodoulou C, Douzenis A, Mommersteeg P, Rallidis L, Poulios A, Efstathiou V, et al.
Ann Gen Psychiatry
. 2013 Nov;
12(1):38.
PMID: 24283252
Background: Type D personality has been associated with a variety of emotional and social difficulties as well as with poor prognosis in patients with established coronary heart disease (CHD). We...
8.
Karamanou A, Hamodraka E, Vrakas S, Paraskevaidis I, Lekakis I, Kremastinos D
Eur J Haematol
. 2013 Oct;
92(1):59-65.
PMID: 24118422
Background: β-thalassemia major is a unique disease characterized by early severe diastolic dysfunction, due to iron myocardial deposition alone, while left ventricular systolic dysfunction and failure seem to be multifactorial...
9.
Kostopoulou A, Tsiapras D, Chaidaroglou A, De Giannis D, Farmakis D, Kremastinos D
Am J Hematol
. 2013 Sep;
89(1):13-8.
PMID: 24038100
Iron deposition in combination with inflammatory and immunogenetic factors is involved in the pathophysiology of cardiac dysfunction in β-thalassemia major. We investigated the mechanical and endocrine function of the left...
10.
Iliodromitis K, Farmakis D, Andreadou I, Zoga A, Bibli S, Manolaki T, et al.
Int J Cardiol
. 2012 Dec;
168(2):1336-41.
PMID: 23270747
Background: Preconditioning (PreC) and postconditioning (PostC) reduce infarct size. We sought to determine the effects of PreC and PostC, alone or in combination, on infarct size and expression of intracellular...